Penn State startup Illuminate Therapeutics is working to create a potent and targeted treatment for head and neck cancers that would cause minimal damage to healthy surrounding tissues. The potential treatment leverages Illuminate’s Light Activated Drug Delivery and Release platform, or LADDR.